Shanghai Chicmax Cosmetic Co., Ltd.: history, ownership, mission, how it works & makes money

From its 2002 origins as Shanghai Kaka Cosmetic Co., Ltd. to a 2015 rebrand and a landmark December 2022 Hong Kong Main Board listing under ticker 2145.HK that raised HK$910.4 million, Shanghai Chicmax Cosmetic Co., Ltd. has surged into China's beauty spotlight-reporting 2024 revenue of ¥6.79 billion (up 62.1% YoY) and net profit of ¥781 million (up 69.4%), with flagship brand Kans driving ¥5.59 billion or 82.3% of sales; boasting a market capitalization of about HK$33.94 billion as of December 2025, 398.11 million shares outstanding, insiders holding 39.32% and institutional investors 2.16%, and recent governance moves such as appointing employee representative Director Sun Hao effective September 25, 2025-Chicmax pairs a multi-brand strategy (Kans, One Leaf, Baby Elephant), dual R&D centers in China and Japan, self-owned production and mixed online/offline distribution with aggressive marketing (marketing expenses rose 90% in 2024) to fuel growth that delivered a 59.3% CAGR in revenue and 130.5% CAGR in net profit from 2022-2024, while industry recognition (top five domestic cosmetics by retail sales per Frost & Sullivan, 2021) and commitments to R&D, sustainability and customer-centricity point to continued expansion into mid-to-high-end and international markets.

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK): Intro

• 2002 - Founded as Shanghai Kaka Cosmetic Co., Ltd., focused on R&D, manufacturing and sales of skincare and maternity products.
• 2015 - Rebranded to Shanghai Chicmax Cosmetic Co., Ltd., shifting strategically to a multi-brand approach and brand-building initiatives.
• December 2022 - Listed on the Main Board of the Hong Kong Stock Exchange under ticker 2145.HK; IPO raised HK$910.4 million, marking Chicmax as the first mainland Chinese cosmetics company listed in Hong Kong.
• 2024 - Reported strong growth: revenue of RMB 6.79 billion (up 62.1% YoY) and net profit of RMB 781 million (up 69.4% YoY).

• Publicly listed entity: Hong Kong Main Board, ticker 2145.HK.
• Major brands under the group include Kans (core), and additional owned/operated brands targeting different demographics and channels.
• Vertical integration: in-house R&D, manufacturing facilities, and brand & channel management to control margins and product quality.

• Mission: Build leading Chinese skincare brands through product innovation, consumer-centric branding, and channel diversification.
• Strategic priorities include premiumization of core brands, accelerated omnichannel distribution (offline retail expansion + e-commerce), and continuous R&D investment.

• Product development: R&D teams develop formulations across skincare and maternity care categories, targeting mass to premium market segments.
• Manufacturing: Owns or controls manufacturing capacity for quality and cost control, enabling faster product cycles and margin management.
• Branding & marketing: Invests in brand upgrades, advertising, KOL/KOC campaigns, and packaging/positioning to drive SKU productivity and ASP uplift.
• Distribution: Omnichannel - department stores, specialty cosmetics retailers, brand-owned stores, pharmacies, and digital platforms (Tmall, JD, social commerce).
• After-sales & loyalty: CRM and membership programs to boost repeat purchase rates and lifetime value.

• Product sales - primary revenue from skincare and maternity product lines; Kans is the dominant revenue contributor.
• Channel mix - retail wholesale, direct retail (brand stores), e-commerce and cross-border sales; channel expansion drives volume and ASP improvements.
• Private label / OEM - occasional third-party manufacturing and collaborations to better utilize production capacity.
• Gross margin drivers - product mix (premium SKUs), scale in manufacturing, and channel mix optimization.

• Brand upgrade initiatives fueling ASP increases and higher-margin SKUs.
• Rapid channel expansion - increasing offline store footprint and e-commerce penetration to capture broader consumer cohorts.
• R&D and new product launches targeting skin health trends and maternity/natural ingredient demand.
• Economies of scale in production lowering unit costs as volumes grow.

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK): History

• Founded: early 2000s - started as a manufacturer and OEM supplier.
• Transition to branded products: mid-2010s - launched own portfolio across skincare and colour cosmetics.
• Expansion: invested in R&D labs, manufacturing capacity and digital sales channels (2015-2023).
• Corporate governance update: Mr. Sun Hao appointed as employee representative Director effective September 25, 2025.

• Product portfolio: proprietary brands, contract manufacturing for third parties, and private label production.
• Channels: retail distribution (brick-and-mortar), cross-border and domestic e‑commerce, and B2B OEM clients.
• Value drivers: R&D-led product innovation, scale manufacturing, brand marketing and international partnerships.

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK): Ownership Structure

• Commitment to high-quality, innovative cosmetic and maternity-care solutions across varied consumer segments.
• Substantial investment in R&D to sustain product differentiation and extend clinical/efficacy credentials.
• Sustainability initiatives targeting reduced environmental impact via eco-friendly packaging and sustainable sourcing.
• Customer-centric approach prioritizing product efficacy, safety, and post-sale support to drive repeat purchase and brand loyalty.
• Culture of inclusivity and diversity to ensure product fit for broad demographic and lifecycle needs (including maternity).
• Operational integrity and transparency to build trust with consumers, regulators, investors, and partners.

• Product development: in-house R&D teams + external clinical partners develop formulations for skincare and maternity care.
• Manufacturing & supply chain: owned and contracted GMP-compliant production facilities produce finished goods for retail and e-commerce channels.
• Sales channels: a mix of domestic retail distributors, chain cosmetics stores, hospitals/obstetric channels (for maternity care), cross-border e-commerce, and direct online stores.
• Marketing & brand-building: investment in digital marketing, KOL collaborations, and physician endorsements for maternity-related products.
• Revenue drivers: product mix (core skincare vs. maternity lines), channel mix (offline vs. online), and price tier (mass-premium positioning).

• Major shareholders: a mix of founding/controlling shareholders, institutional investors, and public float on the Hong Kong Stock Exchange (2145.HK).
• Governance: board of directors with independent non-executive directors and audit/compensation committees to ensure transparency and investor protection.
• Capital allocation: prioritizes R&D and channel expansion, balanced with shareholder returns and working capital needs for inventory-intensive retail operations.

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK): Mission and Values

• Multi-brand portfolio: Chicmax manages distinct brands-Kans, One Leaf, and Baby Elephant-targeting mass skincare, natural/heritage positioning, and baby/juvenile care respectively.
• Dual R&D centers: Two R&D hubs (main R&D center in China and a technical/innovation center in Japan) enable local market responsiveness plus access to advanced formulation and safety testing.
• Omnichannel distribution: Products are sold through a combination of e-commerce marketplaces, brand flagship stores, third-party online retailers, pharmacy chains, and department/beauty retail outlets.
• Self-owned production: The company operates its own manufacturing facilities to control quality, scale seasonal production, and shorten lead times for new SKUs.
• Centralized management: Corporate functions (finance, supply chain, brand strategy) are centralized to ensure coordinated product launches, pricing strategy, and margin management across brands.
• Adaptive marketing: Marketing teams continuously reallocate spend to digital ecosystems (short-video, livestreaming, KOL collaborations) while maintaining offline experiential initiatives.

• Product sales: Primary revenue from branded skincare, personal care and infant products sold through direct and partner channels.
• Channel diversification: Higher-margin direct-to-consumer (flagship stores & brand-owned e-commerce) complemented by wholesale to large online marketplaces and brick-and-mortar retailers.
• SKU and seasonal mix: Frequent limited editions and seasonal SKUs drive short-term sales spikes through promotions and livestream events.
• Contract manufacturing flexibility: Owning production enables cost control, shorter product cycle times, and opportunistic capacity use to meet peak demand.
• R&D-driven premiumization: New formulations and ingredient claims (backed by Japan-China R&D collaboration) support up‑trading and improved ASPs for core SKUs.
• Marketing ROI focus: Rapid reallocation of digital ad spend and KOL tie-ups optimize CAC and conversion in real time.

• Product portfolio breadth: Hundreds of SKUs across the three flagship brands, with regular new launches to capture trending demand.
• Channel mix elasticity: Online-first brands can shift spend to livestreaming or marketplace promotions to generate immediate sales uplifts during campaigns.
• Factory-driven agility: Self-owned lines permit accelerated production ramp-up during promotional seasons and limited-edition launches.

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK): How It Works

• Primary revenue driver: direct sale of cosmetic products under multiple brands, led by flagship brand Kans.
• Channel mix: a combination of online e-commerce platforms and offline retail/distribution partners to maximize reach and convenience.
• Product strategy: continuous R&D and quality control to support premium positioning and repeat purchase behavior.
• Marketing: intensified promotional spending and brand campaigns to accelerate customer acquisition and retention.

• Revenue diversification:
  • Skincare (largest share, dominated by Kans)
  • Maternity & childcare (targeting new mothers and family care)
  • Personal care (daily-use items)
  • Makeup (cosmetics and color cosmetics)
• How sales convert to profit:
  • Product margins from in-house manufacturing and branded pricing
  • Volume scale from Kans driving fixed-cost absorption
  • Higher marketing spend to boost top-line growth and long-term customer LTV

Shanghai Chicmax Cosmetic Co., Ltd. (2145.HK): How It Makes Money

• Ranking: Chicmax ranks among the top five Chinese domestic cosmetics companies in terms of retail sales (Frost & Sullivan, 2021).
• Multi-brand strategy: Operates multiple brands positioned across mass, mid-market, and mid-to-high-end segments to capture diverse consumer demographics and price points.
• Channel mix: Revenue derived from a blend of e-commerce, brick-and-mortar retail partnerships, and direct-to-consumer channels.

• Product sales across skincare, color cosmetics, and personal care lines-primary revenue driver.
• Premiumization: Introduction of mid-to-high-end SKUs to increase average selling price (ASP) and margins.
• Private label and OEM/ODM services for third parties, leveraging manufacturing capability and scale.
• Cross-border e-commerce and international distribution partnerships to capture overseas demand.

• R&D investment to accelerate product innovation and differentiated formulations aimed at higher-margin segments.
• Brand architecture optimization to move upmarket while retaining cost-effective mainstream offerings.
• Capital market use: Hong Kong listing (2145.HK) to attract international investors, partners, and facilitate overseas expansion.